Obesity
- Health
Cardiovascular medicines are changing the health risks of obesity
Obesity and Cardiovascular Health: A Closer Look at the Latest Research Is it true that people with obesity have worse…
Read More » - Health
Heat waves, presidential fitness test, obesity data: Morning Rounds
Theresa Gaffney, the lead Morning Rounds writer at STAT, brings you the latest updates on health and medicine. Her stories…
Read More » - Top Stories
Active ingredient in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those with obesity: Study
A groundbreaking new study has found that the active ingredient in popular weight-loss drugs may also have the potential to…
Read More » - Health
Defining obesity or delaying care? New paper stirs medical debate
Obesity is a topic that continues to spark debate, with the focus now shifting towards redefining how we measure and…
Read More » - Top Stories
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk is taking legal action against online telehealth provider Hims & Hers for marketing cheaper, unapproved versions of the…
Read More » - Health
Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers announced on Saturday that it would discontinue the sale of a compounded version of Novo Nordisk’s obesity…
Read More » - Health
Employers drop obesity drug coverage as cash-pay programs grow
HCA Healthcare, one of the largest hospital systems in the U.S., recently made a decision that has caught the attention…
Read More » - Health
WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”
The World Health Organization (WHO) has released new guidelines recommending the use of GLP-1 drugs for the treatment of obesity.…
Read More » - Health
World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know
The World Health Organization has recently issued global guidance on the use of GLP-1 drugs for the treatment of obesity,…
Read More » - Health
Trump’s Price Cuts For Obesity Drugs Raise More Questions Than Answers
President Trump made headlines today with the announcement of agreements with pharmaceutical giants Novo Nordisk and Eli Lilly to lower…
Read More »